Biotech

All Articles

Gene editor Volume laying off 131 workers

.Just days after gene publisher Volume Biosciences introduced confidential functional slices, a clea...

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapy is laying off an one-fourth of its own staff as the oncology biotech scales back its...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually gotten yet another measure toward recognizing a return on its $6....

Gain's period 1 gain leads way to confirm Parkinson's drug's worth

.Increase Therapeutics has actually established its sights on proving the efficiency of its Parkinso...

Actinogen documents new stage 2 records to recover depression medicine

.Actinogen Medical's hopes-- and sell price-- have actually recoiled a little from previously this m...

Pfizer as well as Flagship incorporate Ratio to multibillion-dollar equation

.Front Runner Pioneering as well as Pfizer have included Quotient into their 10-program alliance, in...

Bayer markers $547M contract to drive limits of noncoding RNA

.Bayer executives were actually eager to tension to Intense this summer season that the German pharm...

UK unveils strategies to launch 18 brand new professional trial hubs

.Surrounded by a yearslong professional test downtrend in the U.K., a brand-new public-private allia...

UPDATE: Genentech telegrams 93 unemployments in The golden state after discussing programs to shutter cancer immunology analysis system

.Adhering to the announcement of a huge unemployment round in April and a major rebuilding initiativ...

Neurocrine's KarXT rival reaches in phase 2-- but just at low dosage

.Neurocrine Biosciences has obtained its hoped-for profile in a stage 2 mental illness trial, provid...